soul trial oral semaglutide cardiovascular outcomes trial results 2024 2025 nejm Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Results Oral Semaglutide Significantly Improves Cardiovascular

Bottom Line on Cost: For Cash-Pay Patients: Best value: Compounded semaglutide at $199/month Maximum results: Compounded tirzepatide at $349/month Avoid: Brand-name at $1,000+/month (unsustainable) With Good Insurance: Try savings cards: May get $25/month brand-name If high copays: Compounded may be cheaper Factor in: Total out-of-pocket including deductibles Plan for long-term treatment costsobesity is a chronic condition requiring sustained therapy

Ethics declarations Ethics approval and consent to participate All applicable international, national, and/or institutional guidelines for the care and use of animals were followed

Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials

I feel super amazing